27
posted ago by Narg ago by Narg +27 / -0

https://jessicar.substack.com/p/a-new-pre-print-answers-some-questions

Using a toxic substance as the "placebo" in a trial would, of course, tend to hide or minimize any toxicity of the drug being tested.

The paper is important because it addresses the reality of immune dysregulation due to the presence of the empty LNPs in real people, and shows that in older people, this dysregulation is more astute. I am quite impressed at the number of human subjects they recruited actually: human trials are hard to do. Kudos.

The authors claim that the results suggest that we need better vaccines for older people.

I claim that LNPs should not be used as delivery vehicles for other toxic products like modified messenger RNAs. [Bold added]